← Osler Internal Medicine Residency
ORCID 0000-0002-2573-5260
Johns Hopkins University
Tarek HarbMD
MD · American University of Beirut
Residency · Osler Internal Medicine Residency, Johns Hopkins University
publications
24
first author
4
median RCR
1.77
citations
252
Publications
- 2026Lipoprotein(a) is associated with coronary inflammation in people with HIV and undetectable HIV RNA.European heart journal. Imaging methods and practice0 citesPMID 41852837
- 2025Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical Trial.JACC. Basic to translational scienceRCR 3.1510 citesPMID 40439630
- 2025Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation.Scientific reportsRCR 1.775 citesPMID 39929946
- 2025Lipoprotein(a) in clinical practice: Risk stratification and therapeutic strategies.European journal of clinical investigation3 citesPMID 41044889
- 2025Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel diseaseAmerican Journal of Preventive Cardiology3 citesPMID 40469220
- 2025
- 2025The biology of lipoprotein(a): From genetics to molecular mechanisms.European journal of clinical investigation2 citesPMID 41042035
- 2025Lp(a) in Argentina: Regional data reinforce a global risk factor.Atherosclerosisfirst author0 citesPMID 41314765
- 2025Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab.Atherosclerosis2 citesPMID 40780143
- 2024Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate riskEuropean Heart Journal Openfirst authorRCR 6.5734 citesPMID 39219855
- 2024Neurocardiac Axis Physiology and Clinical Applications.International journal of cardiology. Heart & vasculatureRCR 1.919 citesPMID 39224460
- 2024Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part two: Current and emerging concepts in the clinical use of PCSK9 inhibition.European journal of clinical investigationRCR 1.107 citesPMID 38924090
- 2024Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells.Journal of cardiovascular pharmacologyfirst authorRCR 0.744 citesPMID 39270008
- 2024Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition-Part one: Pleiotropic pro-atherosclerotic effects of PCSK9.European journal of clinical investigationRCR 0.734 citesPMID 38922860
- 2024Homocysteine modifies the association of coronary stenosis and HIV infection in an inner city African American population.International journal of STD & AIDSRCR 0.000 citesPMID 38531830
- 2023Defining Misinformation and Related Terms in Health-Related Literature: Scoping ReviewJournal of Medical Internet ResearchRCR 4.6027 citesPMID 37556184
- 2023Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up.European heart journal openRCR 3.7933 citesPMID 37095769
- 2023Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.European heart journal. Cardiovascular pharmacotherapyRCR 3.2628 citesPMID 37468450
- 2023Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterolCirculation: Cardiovascular Imagingfirst authorRCR 1.1311 citesPMID 37772401
- 2023Coronary artery endothelial function and aging in people with HIV and HIV-negative individuals.American journal of physiology. Heart and circulatory physiologyRCR 0.443 citesPMID 37682238
- 2023Novel Diagnostic Imaging Approach for Patients With Spontaneous Coronary Artery Dissection: The Utility of 18 F-FDG PET Imaging.Clinical nuclear medicineRCR 0.000 citesPMID 37385236
- 2022A Framework for the Development of Living Practice Guidelines in Health CareAnnals of Internal MedicineRCR 6.2067 citesPMID 35785533
Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.